We use cookies for a better user experience. Read our Privacy Policy

I Agree

Gastrointestinal Bleeding Treatment Market

Gastrointestinal Bleeding Treatment Market (Product - Endoscopic Hemostatic Devices, Closure Devices; GI Tract Division - Upper GI Tract, Lower GI Tract; End user - Hospitals, Ambulatory Surgical Centers, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026

Global Gastrointestinal Bleeding Treatment Market - Snapshot

Gastrointestinal bleeding is also known as gastrointestinal hemorrhage. It includes all forms of bleeding of gastrointestinal tract, from the mouth to the rectum. Endoscopic hemostatic devices are the primary line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic devices include thermal and mechanical.

global_gastrointestinal_bleeding_treatment_market

The global gastrointestinal bleeding treatment market is anticipated to expand at a CAGR of 4.5% during the forecast period. Growth of the market can be attributed to rise in demand for endoscopic hemostasis which is considered the first line of treatment for gastrointestinal bleeding, increase in geriatric population, surge in applications of endoscopic hemostasis, significant product launches, strategic acquisitions by key players, and government and non-government funding for research and to spread awareness about gastrointestinal bleeding treatment. However, shortage of trained gastroenterologists, significant product recalls, and limitations of endoscopic treatment are likely to hamper the growth of the global market.

In terms of product, the global gastrointestinal bleeding treatment market has been segmented into endoscopic hemostatic devices, closure devices, and others. The endoscopic hemostatic devices segment has been categorized into mechanical devices and thermal devices. The thermal devices sub-segment dominated the endoscopic hemostatic devices segment in 2017. However, the mechanical devices sub-segment is anticipated to expand at a high CAGR during the forecast period. Growth of the segment can be attributed to increase in usage of these devices for the treatment of upper GI tract bleeding. For instance, band ligation is considered to be the first line of treatment for esophageal varices.

Based on GI tract division, the global gastrointestinal bleeding treatment market has been classified into upper GI tract and lower GI tract. The upper GI tract segment dominated the market in 2017 and the trend is likely to continue during in the forecast period. Growth of the segment can be attributed to increase in the number of hospitalizations owing to upper GI tract bleeding. Upper GI tract bleeding is one of the common emergencies reported and accounts for over 250,000 hospitalizations in the U.S. and over 300,000 hospitalizations in the U.K. each year. Peptic ulcer which is one of the common causes of upper GI tract bleeding is known to have significant prevalence owing to increase in H. pylori infections.

In terms of end-user, the global gastrointestinal bleeding treatment market has been divided into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2017. It is expected to continue to dominate the market during the forecast period. Hospitals are major end-users of endoscopic hemostatic devices. According to government health care facilities, hospitals have reimbursement plans and systems with advanced technology for disease treatment. Growth of the segment is attributed to increase the number of treatments and hospital facilities across the world. According to the American Hospital Association, the total number of registered hospitals in the U.S. stood at nearly 5,686 in 2015.

In terms of region, the global gastrointestinal bleeding treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe accounted for over 75% share of the market in 2018. The two regions are anticipated to continue to dominate the global market in terms of revenue during the forecast period. North America is expected to dominate the global market during the forecast period owing to the presence of leading market players and strategic mergers and partnerships among players. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Growth of the market in the region is attributed to increase in the geriatric population, rise in prevalence of GI bleeding with age, and growing focus of market players on exploiting the untapped markets in India and Japan.

Key companies operating in the global gastrointestinal bleeding treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC.

Intensive Smoking and Drinking Habits leading to Intestinal Diseases to Aid in Expansion of Gastrointestinal Bleeding Treatment Market

Gastrointestinal bleeding is otherwise called gastrointestinal drain. It incorporates all types of bleeding of gastrointestinal parcel, from the mouth to the rectum. Endoscopic hemostatic gadgets are the essential line of treatment for gastrointestinal bleeding. The major endoscopic hemostatic gadgets incorporate warm and mechanical. Development of the market can be credited to ascend sought after for endoscopic hemostasis which is viewed as the primary line of treatment for gastrointestinal bleeding, expansion in geriatric populace, flood in uses of endoscopic hemostasis, critical item dispatches, vital acquisitions by central participants, and government and non-government financing for research and to spread mindfulness about gastrointestinal bleeding treatment. In any case, lack of prepared gastroenterologists, critical item reviews, and restrictions of endoscopic treatment are probably going to hamper the development of the worldwide market.

The fundamental driver of gastrointestinal (GI) bleeding is concentrated smoking and liquor utilization that seriously influences gastric emissions. The adjustment of way of life designs has expanded the quantity of cases with GI bleeding. the rising accomplishment of endoscopy treatments has prompted the interest for endoscopy hemostatic techniques for GI bleeding treatment. It is utilized as a broad instrument to stop dynamic bleeding and forestall rebleeding. The quantity of individuals matured over 65 and experiencing GI bleeding and request from this age bunch is expanding and accordingly driving the market. Expanded financing in medical clinics has brought request up on the lookout. In any case, the excessive cost of endoscopy gadgets may hamper market development.

Ascend in commonness of gastrointestinal bleeding with age, expansion in occurrence of re-bleeding cases, and flood in appropriation of endoscopic hemostasis as the essential line of treatment for gastrointestinal bleeding add to the development of the worldwide market. Higher pace of hospitalization because of upper GI lot bleeding, higher pervasiveness than lower GI lot bleeding, and simplicity of analysis of upper GI plot bleeding add to the development of the portion. Besides, rate of upper gastrointestinal bleeding ascends with age attributable to increment in utilization of non-steroidal calming drugs (NSAIDs) which incite ulcerogenensis in older patients. As per government medical services offices, emergency clinics have repayment plans and frameworks with cutting edge innovation for illness treatment. Development of the section is ascribed to expand the quantity of treatments and emergency clinic offices across the world.

The global gastrointestinal bleeding treatment market has been segmented as follows:

Product

  • Endoscopic Hemostatic Devices
    • Thermal Devices
    • Mechanical Devices
  • Closure Devices
  • Others

GI Tract Division

  • Upper GI Tract
  • Lower GI Tract

End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of gastrointestinal bleeding treatment market?

The global gastrointestinal bleeding treatment market was worth US$ 575.3 Mn and is projected to reach a value of US$ 849.8 Mn by the end of 2026

What is the anticipated CAGR of the gastrointestinal bleeding treatment market in the forecast period?

Gastrointestinal bleeding treatment market is anticipated to grow at a CAGR of 4.5% during the forecast period

Which region is expected to project the highest market share in the global gastrointestinal bleeding treatment market?

North america accounted for a major share of the global gastrointestinal bleeding treatment market

What are the key driving factors for the growth of the gastrointestinal bleeding treatment market?

The quantity of individuals matured over 65 and experiencing GI bleeding and request from this age bunch is expanding and accordingly driving the gastrointestinal bleeding treatment market

Who are the key players in the global gastrointestinal bleeding treatment market?

Key players in the global gastrointestinal bleeding treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC.

    1. Preface 
          1.1. Market Definition and Scope
          1.2. Market Segmentation 
          1.3. Key Research Objectives
          1.4. Research Highlights

    2. Assumptions and Acronyms Used

    3. Research Methodology 

    4. Executive Summary

    5. Market Overview
          5.1. Product Overview
          5.2. Market Dynamics
                  5.2.1. Drivers
                            5.2.1.1. Increase in geriatric population
                            5.2.1.2. Government and non-government funding
                            5.2.1.3. High prevalence of upper gastrointestinal bleeding
                            5.2.1.4. Rise in applications of endoscopic hemostasis
                            5.2.1.5. Significant product launches
                            5.2.1.6. Strategic acquisitions
                  5.2.2. Restraints
                            5.2.2.1. Dearth of skilled labor
                            5.2.2.2. Product recalls
                            5.2.2.3. Limitations of endoscopic management
                  5.2.3. Opportunities
                            5.2.3.1. Increase in adoption of combination therapy
                            5.2.3.2. Untapped emerging economies 
          5.3. Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2016?2026
          5.4. Global Gastrointestinal Bleeding Treatment Market Outlook
          5.5. Key Industry Developments
          5.6. Technological Advancements
          5.7. Disease Epidemiological Assessment 
          5.8. Global Incidence of Gastrointestinal Cancers by Region 
          5.9. Reimbursement Scenario Assessment 
          5.10. Strategies Adopted by Top 3 Players
          5.11. Healthcare Overview 

    6. Global Gastrointestinal Bleeding Treatment Market Analysis, by Product 
          6.1. Introduction
          6.2. Key Findings
          6.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product 
          6.4. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016?2026
                  6.4.1. Endoscopic Hemostatic Devices 
                            6.4.1.1. Thermal Devices
                            6.4.1.2. Mechanical Devices
                  6.4.2. Closure Devices 
                  6.4.3. Others
          6.5. Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026

    7. Global Gastrointestinal Bleeding Treatment Market Analysis, by GI Tract Division
          7.1. Introduction
          7.2. Key Findings
          7.3. Market Value Share Analysis, by GI Tract Division
          7.4. Market Value Forecast, by Procedure, 2016–2026
                  7.4.1. Upper GI Tract Division 
                  7.4.2. Lower GI Tract Division
          7.5. Market Attractiveness, by GI Tract Division

    8. Global Gastrointestinal Bleeding Treatment Market Analysis, by End-user
          8.1. Introduction
          8.2. Key Findings
          8.3. Market Value Share Analysis, by End-user
          8.4. Market Value Forecast, by End-user, 2016–2026
                  8.4.1. Hospitals 
                  8.4.2. Clinics
                  8.4.3. Ambulatory Surgical Centers
                  8.4.4. Others
          8.5. Market Attractiveness, by End-user

    9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecasts, by Region
          9.1.  Introduction 
          9.2. Regional Outlook
          9.3.  Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Region, 2016–2026 
                  9.3.1. North America 
                  9.3.2. Europe 
                  9.3.3. Asia Pacific
                  9.3.4. Latin America
                  9.3.5. Middle East & Africa 
          9.4. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region 

    10. North America Gastrointestinal Bleeding Treatment Market Analysis
          10.1. Key Findings
          10.2. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Country, 2016?2026
                  10.2.1. U.S.
                  10.2.2. Canada
          10.3. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
                  10.3.1. Endoscopic Hemostatic Devices 
                            10.3.1.1. Thermal Devices
                            10.3.1.2. Mechanical Devices
                  10.3.2. Closure Devices 
                  10.3.3. Others
          10.4. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
                  10.4.1. Upper GI Tract 
                  10.4.2. Lower GI Tract
          10.5. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
                  10.5.1. Hospitals
                  10.5.2. Clinics
                  10.5.3. Ambulatory Surgical Centers
                  10.5.4. Others
          10.6. North America Market Attractiveness Analysis
                  10.6.1. By Country
                  10.6.2. By Product 
                  10.6.3. By GI Tract Division
                  10.6.4. By End-user

    11. Europe Gastrointestinal Bleeding Treatment Market Analysis
          11.1. Key Findings
          11.2. Europe Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
                  11.2.1. Germany
                  11.2.2. U.K.
                  11.2.3. France
                  11.2.4. Italy
                  11.2.5. Spain
                  11.2.6. Rest of Europe
          11.3. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
                  11.3.1. Endoscopic Hemostatic Devices 
                            11.3.1.1. Thermal Devices
                            11.3.1.2. Mechanical Devices
                  11.3.2. Closure Devices 
                  11.3.3. Others
          11.4. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
                  11.4.1. Upper GI Tract 
                  11.4.2. Lower GI Tract
          11.5. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
                  11.5.1. Hospitals
                  11.5.2. Clinics
                  11.5.3. Ambulatory Surgical Centers
                  11.5.4. Others
          11.6. Europe Market Attractiveness Analysis
                  11.6.1. By Country/Sub-region
                  11.6.2. By Product 
                  11.6.3. By GI Tract Division
                  11.6.4. By End-user

    12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis
          12.1. Key Findings
          12.2. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
                  12.2.1. China
                  12.2.2. India
                  12.2.3. Japan
                  12.2.4. Australia
                  12.2.5. Rest of Asia Pacific 
          12.3. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
                  12.3.1. Endoscopic Hemostatic Devices 
                            12.3.1.1. Thermal Devices
                            12.3.1.2. Mechanical Devices
                  12.3.2. Closure Devices 
                  12.3.3. Others
          12.4. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
                  12.4.1. Upper GI Tract 
                  12.4.2. Lower GI Tract
          12.5. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
                  12.5.1. Hospitals
                  12.5.2. Clinics
                  12.5.3. Ambulatory Surgical Centers
                  12.5.4. Others
          12.6. Asia Pacific Market Attractiveness Analysis
                  12.6.1. By Country/Sub-region
                  12.6.2. By Product 
                  12.6.3. By GI Tract Division
                  12.6.4. By End-user

    13. Latin America Gastrointestinal Bleeding Treatment Market Analysis
          13.1. Key Findings
          13.2. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
                  13.2.1. Brazil
                  13.2.2. Mexico
                  13.2.3. Rest of Latin America
          13.3. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
                  13.3.1. Endoscopic Hemostatic Devices 
                            13.3.1.1. Thermal Devices
                            13.3.1.2. Mechanical Devices
                  13.3.2. Closure Devices 
                  13.3.3. Others
          13.4. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
                  13.4.1. Upper GI Tract 
                  13.4.2. Lower GI Tract
          13.5. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
                  13.5.1. Hospitals
                  13.5.2. Clinics
                  13.5.3. Ambulatory Surgical Centers
                  13.5.4. Others
          13.6. Latin America Market Attractiveness Analysis
                  13.6.1. By Country/Sub-region
                  13.6.2. By Product 
                  13.6.3. By GI Tract Division
                  13.6.4. By End-user

    14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis
          14.1. Key Findings
          14.2. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026
                  14.2.1. GCC Countries 
                  14.2.2. Israel 
                  14.2.3. South Africa 
                  14.2.4. Rest of Middle East & Africa
          14.3. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016–2026
                  14.3.1. Endoscopic Hemostatic Devices 
                  14.3.1.1. Thermal Devices
                  14.3.1.2. Mechanical Devices
                  14.3.2. Closure Devices 
                  14.3.3. Others
          14.4. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016–2026
                  14.4.1. Upper GI Tract 
                  14.4.2. Lower GI Tract
          14.5. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016–2026
                  14.5.1. Hospitals
                  14.5.2. Clinics
                  14.5.3. Ambulatory Surgical Centers
                  14.5.4. Others
          14.6. Middle East & Africa Market Attractiveness Analysis
                  14.6.1. By Country/Sub-region
                  14.6.2. By Product 
                  14.6.3. By GI Tract Division
                  14.6.4. By End-user

    15. Competitive Landscape
          15.1. Competition Matrix
          15.2. Gastrointestinal Bleeding Treatment Market Share Analysis, by Company, 2018
          15.3. Company Profiles
                  15.3.1. Boston Scientific Corporation 
                            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2. Financial Overview 
                            15.3.1.3. Product Portfolio
                            15.3.1.4. SWOT Analysis
                            15.3.1.5. Strategic Overview
                  15.3.2. Olympus Corporation
                            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.2.2. Financial Overview 
                            15.3.2.3. Product Portfolio
                            15.3.2.4. SWOT Analysis
                            15.3.2.5. Strategic Overview
                  15.3.3. CONMED Corporation
                            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.3.2. Financial Overview 
                            15.3.3.3. Product Portfolio
                            15.3.3.4. SWOT Analysis
                            15.3.3.5. Strategic Overview
                  15.3.4.  Cook Medical
                            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.4.2. Product Portfolio
                            15.3.4.3. SWOT Analysis
                            15.3.4.4.  Strategic Overview
                  15.3.5. Ovesco Endoscopy AG 
                            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.5.2. Financial Overview 
                            15.3.5.3. Product Portfolio
                            15.3.5.4. SWOT Analysis
                            15.3.5.5. Strategic Overview
                  15.3.6. Erbe Elektromedizin GmbH 
                            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.6.2. Financial Overview
                            15.3.6.3. Product Portfolio
                            15.3.6.4. SWOT Analysis
                            15.3.6.5. Strategic Overview
                  15.3.7. Steris, plc
                            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.7.2. Financial Overview
                            15.3.7.3. Product Portfolio
                            15.3.7.4. SWOT Analysis
                            15.3.7.5. Strategic Overview
                  15.3.8. US Medical Innovations, LLC 
                            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.8.2. Product Portfolio
                            15.3.8.3. SWOT Analysis
          

    List of Tables

    Table 01: Causes and their associate factors of Gastrointestinal Bleeding 
    Table 02: Global Estimates of the Number of Incidence for Gastrointestinal Cancers in Male, by Region
    Table 03: Global Estimates of the Number of Incidence for Gastrointestinal Cancers in Female, by Region
    Table 04: CPT Codes- Endoscopic Hemostatic Procedures – Control of Bleeding
    Table 05: CPT Codes- Endoscopic Hemostatic Procedures – Ligation
    Table 06: CPT Codes- Endoscopic Hemostatic Procedures – Injection
    Table 07: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 08: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Table 09: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
    Table 10: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 11: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
    Table 12: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 13: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 14: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Table 15: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
    Table 17: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 18: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 19: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Table 20: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
    Table 21: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 22: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 23: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 24: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Table 25: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
    Table 26: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 27: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 28: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 29: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Table 30: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
    Table 31: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 32: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 33: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 34: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Table 35: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2016–2026
    Table 36: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures 

    Figure 01: Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
    Figure 02: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Forecast, 2018–2026
    Figure 03: Market Value Share, by Product, 2018
    Figure 04: Market Value Share, by GI Tract Division, 2018
    Figure 05: Market Value Share, by End-user, 2018
    Figure 06: Market Value Share, by Region, 2018
    Figure 07: Gastrointestinal Bleeding Treatment – Technological Advances
    Figure 08 Causes- Upper Gastrointestinal Bleeding
    Figure 09: Classification of peptic ulcers
    Figure 10: Types of Lower GI Bleeding
    Figure 11: Causes- Lower Gastrointestinal Bleeding
    Figure 12: Top 3 Players operating in Market Space
    Figure 13: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
    Figure 14: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Endoscopic Hemostatic Devices, 2016–2026
    Figure 15: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Closure Devices, 2016–2026
    Figure 16: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 17: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thermal Devices, 2016–2026
    Figure 18: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mechanical Devices, 2016–2026
    Figure 19: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
    Figure 20: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
    Figure 21: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
    Figure 22: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Upper GI Tract Division, 2016–2026
    Figure 23: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lower GI Tract Division, 2016–2026
    Figure 24: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
    Figure 25: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 26: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016–2026
    Figure 27: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinics, 2016–2026
    Figure 28: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2016–2026
    Figure 29: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 30: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
    Figure 31: Gastrointestinal Bleeding Treatment Market: Regional Outlook
    Figure 32: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 33: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Region, 2017 and 2026
    Figure 34: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Region, 2018-2026
    Figure 35: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 36: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country, 2018–2026
    Figure 37: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country, 2017 and 2026
    Figure 38: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
    Figure 39: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
    Figure 40: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 41: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
    Figure 42: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
    Figure 43: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
    Figure 44: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
    Figure 45: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 46: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 47: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 48: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
    Figure 49: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
    Figure 50: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 51: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
    Figure 52: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
    Figure 53: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
    Figure 54: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
    Figure 55: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 56: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 57: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 58: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
    Figure 59: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
    Figure 60: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 61: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
    Figure 62: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
    Figure 63: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
    Figure 64: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
    Figure 65: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 66: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 67: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 68: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
    Figure 69: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
    Figure 70: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 71: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
    Figure 72: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
    Figure 73: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
    Figure 74: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
    Figure 75: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 76: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 77: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 78: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2017 and 2026
    Figure 79: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2017 and 2026
    Figure 80: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 81: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018?2026
    Figure 82: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2018?2026
    Figure 83: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2018?2026
    Figure 84: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2018?2026
    Figure 85: Global Gastrointestinal Bleeding Treatment Market Share Ana

Copyright © Transparency Market Research, Inc. All Rights reserved